TALEN

TALEN1-cyp24a1

ID

ZDB-TALEN-190906-2

Name

TALEN1-cyp24a1

Previous Names

None

Target

cyp24a1 (1)

Target Sequence 1

5' - GACAACTTTTACGCACG - 3'

Target Sequence 2

5' - GCGCTCTCATCTTGAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
pd272Tg	cyp24a1

Expression

Gene expression in Wild Types + TALEN1-cyp24a1

No data available

Phenotype

Phenotype resulting from TALEN1-cyp24a1

No data available

Phenotype of all Fish created by or utilizing TALEN1-cyp24a1

Phenotype	Fish	Conditions	Figures
liver GFP expression increased amount, abnormal	cyp24a1^pd272Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
heart GFP expression increased amount, abnormal	cyp24a1^pd272Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
whole organism GFP expression increased amount, abnormal	cyp24a1^pd272Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
heart GFP expression amount, ameliorated	cyp24a1^pd272Tg/+; pd273Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
heart GFP expression absent, abnormal	cyp24a1^pd272Tg/+; pd273Tg/+	control	Fig. 2 from Han et al., 2019
liver GFP expression amount, ameliorated	cyp24a1^pd272Tg/+; pd273Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
liver GFP expression amount, ameliorated	cyp24a1^pd272Tg/+; pd276Tg/+	heat shock, chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
heart GFP expression amount, ameliorated	cyp24a1^pd272Tg/+; pd276Tg/+	heat shock, chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
heart GFP expression decreased amount, abnormal	cyp24a1^pd272Tg/+; pd276Tg/+	heat shock	Fig. 2 from Han et al., 2019
cardiac ventricle GFP expression decreased amount, abnormal	cyp24a1^pd272Tg/+; pd301Tg/+	control	Fig. 3 from Han et al., 2019
cardiac ventricle GFP expression increased amount, abnormal	cyp24a1^pd272Tg/+; pd302Tg/+	control	Fig. 3 from Han et al., 2019
heart hyperplastic, abnormal	cyp24a1^pd272Tg/+; pd302Tg/+	control	Fig. 3 from Han et al., 2019
heart GFP expression increased amount, abnormal	cyp24a1^pd272Tg/+; pd302Tg/+	control	Fig. 3 from Han et al., 2019
atrium GFP expression increased amount, abnormal	cyp24a1^pd272Tg/+; pd302Tg/+	control	Fig. 3 from Han et al., 2019
heart GFP expression increased distribution, abnormal	cyp24a1^pd272Tg/+; pd302Tg/+	control	Fig. 3 from Han et al., 2019
heart increased size, abnormal	cyp24a1^pd272Tg/+; pd302Tg/+	control	Fig. 3 from Han et al., 2019
heart GFP expression absent, abnormal	vdra^pd307/pd307; vdrb^pd308/pd308; cyp24a1^pd272Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019
whole organism GFP expression absent, abnormal	vdra^pd307/pd307; vdrb^pd308/pd308; cyp24a1^pd272Tg/+	chemical treatment by environment: alfacalcidol	Fig. 2 from Han et al., 2019

Citations